TITLE

Current Concepts in the Management of Tuberculosis

AUTHOR(S)
Sia, Irene G.; Wieland, Mark L.
PUB. DATE
April 2011
SOURCE
Mayo Clinic Proceedings;Apr2011, Vol. 86 Issue 4, p348
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Tuberculosis (TB) poses a serious threat to public health throughout the world but disproportionately afflicts low-income nations. Persons in close contact with a patient with active pulmonary TB and those from endemic regions of the world are at highest risk of primary infection, whereas patients with compromised immune systems are at highest risk of reactivation of latent TB infection (LTBI). Tuberculosis can affect any organ system. Clinical manifestations vary accordingly but often Include fever, night sweats, and weight loss. Positive results on either a tuberculin skin test or an interferon-γ release assay in the absence of active TB establish a diagnosis of LTBI. A combination of epidemiological, clinical, radiographic, microbiological, and histopathologic features is used to establish the diagnosis of active TB. Patients with suspected active pulmonary TB should submit 3 sputum specimens for acid-fast bacilli smears and culture, with nucleic acid amplification testing performed on at least 1 specimen. For patients with LTBI, treatment with isoniazid for 9 months is preferred. Patients with active TB should be treated with multiple agents to achieve bacterial clearance, to reduce the risk of transmission, and to prevent the emergence of drug resistance. Directly observed therapy is recommended for the treatment of active TB. Health care professionals should collaborate, when possible, with local and state public health departments to care for patients with TB. Patients with drug-resistant TB or coinfection with human immunodeficiency virus should be treated in collaboration with TB specialists. Public health measures to prevent the spread of TB include appropriate respiratory isolation of patients with active pulmonary TB, contact investigation, and reduction of the LTBI burden.
ACCESSION #
59803648

 

Related Articles

  • Global tuberculosis control: lessons learnt and future prospects. Lienhardt, Christian; Glaziou, Philippe; Uplekar, Mukund; Lönnroth, Knut; Getahun, Haileyesus; Raviglione, Mario // Nature Reviews Microbiology;Jun2012, Vol. 10 Issue 6, p407 

    Tuberculosis (TB) is an ancient disease, but not a disease of the past. After disappearing from the world public health agenda in the 1960s and 1970s, TB returned in the early 1990s for several reasons, including the emergence of the HIV/AIDS pandemic and increases in drug resistance. More than...

  • JOURNAL WATCH.  // Nation's Health;Sep2001, Vol. 31 Issue 8, p45 

    Highlights several public health topics published in the August 2001 issue of the `American Journal of Public Health.' Acceptance of oral tests to detect HIV; Risk of death from infectious diseases in African-Americans; Decrease of chlamydia infection in women.

  • Survival from XDR-TB Is Associated with Modifiable Clinical Characteristics in Rural South Africa. Shenoi, Sheela V.; Brooks, Ralph P.; Barbour, Russell; Altice, Frederick L.; Zelterman, Daniel; Moll, Anthony P.; Master, Iqbal; Merwe, Theo L. van der; Friedland, Gerald H. // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Background: Drug-resistant tuberculosis (TB) is a major threat to global public health. Patients with extensively drugresistant TB (XDR-TB), particularly those with HIV-coinfection, experience high and accelerated mortality with limited available interventions. To determine modifiable factors...

  • Survival from XDR-TB Is Associated with Modifiable Clinical Characteristics in Rural South Africa. Shenoi, Sheela V.; Brooks, Ralph P.; Barbour, Russell; Altice, Frederick L.; Zelterman, Daniel; Moll, Anthony P.; Master, Iqbal; Merwe, Theo L. van der; Friedland, Gerald H. // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Background: Drug-resistant tuberculosis (TB) is a major threat to global public health. Patients with extensively drugresistant TB (XDR-TB), particularly those with HIV-coinfection, experience high and accelerated mortality with limited available interventions. To determine modifiable factors...

  • Outbreak of Multidrug-Resistant Salmonella Typhimurium Associated With Rodents Purchased at Retail Pet Stores—United States, December 2003–October 2004. Smith, K.; Boxrud, D.; Leano, F.; Snider, C.; Braden, C.; Lockett, J.; Montgomery, S.; Swanson, S.; O'Reilly, C. // JAMA: Journal of the American Medical Association;6/22/2005, Vol. 293 Issue 24, p2994 

    Reports research on an outbreak of multidrug-resistant Salmonella enterica serotype Typhimurium in the United States during December 2003 to October 2004. Association of the disease with hamsters received from an Iowa pet distributor; Details of the South Carolina and Minnesota cases; States...

  • Diagnosis & treatment of tuberculosis in HIV co-infected patients. Padmapriyadarsini, C.; Narendran, G.; Swaminathan, Soumya // Indian Journal of Medical Research;Dec2011, Vol. 134 Issue 6, p850 

    Human immunodeficiency virus (HIV) associated tuberculosis (TB) remains a major global public health challenge, with an estimated 1.4 million patients worldwide. Co-infection with HIV leads to challenges in both the diagnosis and treatment of tuberculosis. Further, there has been an increase in...

  • Infecções associadas aos cuidados de saúde e segurança do doente.  // Revista Portuguesa de Saúde Pública / Portuguese Journal of Pu;2010, p27 

    No abstract available.

  • The Emerging Crisis of Drug-Resistant Tuberculosis in South Africa: Lessons from New York City. Murphy, Richard A. // Clinical Infectious Diseases;6/1/2008, Vol. 46 Issue 11, p1729 

    Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis have emerged as important infections in South Africa among patients infected with human immunodeficiency virus (HIV). In the face of this new epidemic, South Africa must rededicate itself to the task of tuberculosis...

  • Low Levels of Antiretroviral-Resistant HIV Infection in a Routine Clinic in Cameroon that Uses the World Health Organization (WHO) Public Health Approach to Monitor Antiretroviral Treatment and Adequacy with the WHO Recommendation for Second-Line... Kouanfack, Charles; Montavon, Celine; Laurent, Christian; Aghokeng, Avelin; Kenfack, Alain; Bourgeois, Anke; Koulla-Shiro, Sinata; Mpoudi-Ngole, Eitel; Peeters, Martine; Delaporte, Eric // Clinical Infectious Diseases;5/1/2009, Vol. 48 Issue 9, p1318 

    A cross-sectional study, performed at a routine human immunodeficiency virus (HIV)/AIDS clinic in Cameroon that uses the World Health Organization public health approach, showed low rates of virological failure and drug resistance at 12 and 24 months after initiation of antiretroviral therapy....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics